Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Chemomab Therapeutics Ltd ADR (NQ: CMMB )

3.030 +0.030 (+1.00%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 27, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 9,901
Open 2.940
Bid (Size) 2.930 (2)
Ask (Size) 3.150 (4)
Prev. Close 3.000
Today's Range 2.880 - 3.180
52wk Range 2.530 - 27.92
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Chemomab Therapeutics: Q1 Earnings Insights
Chemomab Therapeutics (NASDAQ:CMMB) reported its Q1 earnings results on Thursday, May 12, 2022 at 06:00 AM. Here's what investors need to know about the announcement. 
Via Benzinga
Chemomab Therapeutics Earnings Conference Call Is Coming Up, Here's What You Need To Know
Chemomab Therapeutics (NASDAQ:CMMB) will host a conference call at 08:00 AM ET on May 12, 2022, to discuss Q1 2022 earnings results. 
Via Benzinga

Performance

YTD
-57.92%
-57.92%
1 Month
-3.50%
-3.50%
3 Month
-25.00%
-25.00%
6 Month
-65.84%
-65.84%
1 Year
-82.20%
-82.20%

More News

Read More
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Chemomab Therapeutics Reports Q4 EPS $(0.02) Vs. $(0.01) YoY
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Earnings Scheduled For March 9, 2022
Via Benzinga
55 Biggest Movers From Yesterday
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For December 7, 2021
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
The Daily Biotech Pulse: Moderna, Pfizer-BioNTech Ink New Vaccine Deals With UK, GSK-Vir Antibody Show Activity Against Omicron, Chemomab Gets Clearance
Via Benzinga
Exposures COVID-19
FDA Signs Off Chemomab's Lead Candidate Mid-Stage Study In Bile Duct Disease
Via Benzinga
Exposures Product Safety
54 Biggest Movers From Yesterday
Via Benzinga
Topics Government
Exposures Political
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Intraday Session
Via Benzinga
38 Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Topics Government
Exposures Political
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
23 Stocks Moving in Thursday's Pre-Market Session
Via Benzinga
Topics Government
Exposures Political
The Daily Biotech Pulse: NRx Stitches COVID-19 Drug Partnership, Protara Gets Nod For Starting Bladder Cancer Study, IGM Moves Beyond Oncology
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: Allogene Sinks On FDA Clinical Hold, Takeda Gets Adcom Backing, Quidel Reports Q3 COVID Revenues, IPOs
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Moderna Invests In Africa, Amgen Announces Neuroscience R&D Collaboration, Decision Day For Chemocentryx, Biophytis To Restate Results
Via Benzinga
The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.